The medicine cannot be taken
if the following points apply to you. If you are unsure whether this is the case, consult your doctor before taking the product.
You should not take the medicine if:
You have, have had, or are suspected of having breast cancer.
You have a form of cancer that depends on estrogen to grow, for example. B. Cancer of the uterine mucosa (endometrium) or there is appropriate suspicion.
Bleeding from the vagina occurs, the cause of which is not clear.
There is untreated excessive thickening of the uterine lining (endometrial hyperplasia).
You have or have previously had a blood clot in a vein (thrombosis), for example. B. in the legs (deep vein thrombosis) or in the lungs (pulmonary embolism)
You have a bleeding disorder (such as protein C deficiency, protein S deficiency, or antithrombin deficiency)
You have or have ever had a condition caused by blood clots in your arteries, such as: B. Heart attack, stroke, or attacks of chest pain with a feeling of tightness in the chest (angina)
You have or have ever had liver disease and your liver function tests have not yet returned to normal.
You have a rare inherited blood disorder called porphyria.
You have a hypersensitivity (allergy) to estradiol, dydrogesterone, or any other ingredient of this medicine.
If any of the above diseases occur for the first time while taking the drug, stop treatment immediately and consult a doctor immediately.
Femoston 2/10mg Filmtabletten 84 Stk. (Estradiol 2 mg/ Dydrogesteron 10 mg)
€74.44
The drug is used in postmenopausal women whose last menstruation (menopause) was at least 6 months ago.
Description
Additional information
Shipping & Delivery
Related products
PROGYNOVA mite 21 film-coated tablets, 3 × 21 (estradiol-1 mg)
Hot flashes, increased sweating, sleep disorders, depression, nervousness, irritability, headaches, dizziness when menstruation stops during menopause, after surgical removal of the ovaries or their irradiation; hyperesthesia of the bladder, degenerative changes in the skin and mucous membrane, osteoporosis in the climacteric period.
Used mainly as part of combination drugs.
Fosamax, 70mg, 12
What is Fosamax?
The drug Fosamax (alendronic acid) belongs to a group of medicines called bisphosphonates. This drug changes the cycle of formation and breakdown of bone tissue in the body.
Among the main indications for the use of Fosamax tablets is osteoporosis in women after the onset of menopause and in the postmenopausal period, which helps prevent serious pathological conditions such as fractures of the femoral neck, vertebrae, wrist bones and hands. Osteoporosis after menopause is associated with a decrease in estrogen levels, which prevents bone thinning and improves bone quality. As a result of a decrease in this hormone, bone resorption increases, which leads to a decrease in bone mineral density, bones become weakened and more prone to fracture. You can buy Fosamax in our online pharmacy. It is used by women to treat and prevent osteoporosis associated with menopause.
This drug is also commonly used in men to treat osteoporosis caused by steroid use.
Other indications for the use of Fosamax (alendronic acid) include:
Paget's disease (osteitis deformans, osteodystrophy) in women and men
Prevention of osteoporosis (caused by the use of glucocorticoids)
Treatment of osteoporosis in men and women
During treatment with Fosamax, normal bone tissue is formed. In therapeutic doses, alendronic acid does not cause osteomalacia. This drug has proven itself in the treatment of postmenopausal osteoporosis in women due to a significant increase in bone density. Therefore, reviews and reviews of Fosamaka are positive. Data from clinical studies demonstrate the high efficacy of the drug. Read the package insert for Fosamax before starting treatment.
